Reddit Posts
IBRX - I don't understand something
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT
🚨PENNY STOCKS & SMALL CAPS' CATALYSTS - Sept 12!
Dealing with Fears of Loss, that leads to many lost opportunities - help needed
Dealing with Fears of Loss, that leads to many lost opportunities - help needed
June's penny stock marvels: supercharge your portfolio with these gems!
Will $IBRX go to $7 or even $10 by may 23?
IBRX is ready for a squeeze, has just begun.
A List of Biotech Stocks With Major Price Movement and Continued Upside Potential.
$IBRX Strong after hours buying and chart grabbed my attention..$2 break could really send this..news of late points to some big things com.
Penny stocks in focus ($TRKA, $BTBT, $IBRX)
IBRX on the launch pad to double digit area
Top Doctors Discuss Blow Out Phase 3 results of Immunity Bio Quilt Study to treat bladder cancer
IBRX ImmunityBio has the vaccine for all covid variants and more
IBRX ImmunityBio has the cure for all covid variants
IBRX expecting BLA submission to FDA this month
$IBRX I am an idiot. I’m all in and I’m getting a biblical ass pounding. Every fucking stock I buy, it dies. #mayor of tard-city
$IBRX. I am an idiot. Tell me why I am being a tard and blowing away my paycheck on this pile of dogeshit.
$IBRX , $AMRS. Complete Joint Venture. NFA.
A Keytruda competitor has a BLA filing and the market is overlooking them!
Immunitybio is the next big thing or will they fade away due to the greed of the fat suits?
Apes 🦍 needed to End Covid - Buy IBRX - 1st 2nd Gen Vaccine
IBRX ImmunityBio announces primary endpoint met in bladder cancer trial
IBRX stock is one to get in on
https://www.streetinsider.com/Corporate+News/ImmunityBio+%28IBRX%29+Announces+Positive+Durable+Responses+in+BCG+Unresponsive+Bladder+Cancer+Patients+with+a+Complete+Response+Rate+of+72%25%2C+Median+Duration+of+Complete+Response+of+19.9+Months%2C+and+85%25+R/18931016.html
ImmunityBio (IBRX) Announces Positive Durable Responses in BCG Unresponsive Bladder Cancer Patients with a Complete Response Rate of 72%, Median Duration of Complete Response of 19.9 Months, and 85% R
$IBRX their bladder cancer treatment is nearly 2x more effective than the leading treatment.
IBRX, Immunitybio, 72% Complete Response for bladder cancer
IBRX, Immunitybio, 72% Complete Response for bladder cancer
IBRX, Immunitybio, 72% Complete Response for bladder cancer
Mentions
Made some good money yesterday on DFLI and MVST. MVST is a long term play. Selling that when it buys me a car. DFLI is a 2-6month play for me. Still holding BURU and ATCH because I’m still 100%+ gains on both and have sold the majority of both positions at their peak so letting the rest ride to see if we get some late action. MBOT, IXHL, ICU, IBRX, are ones that I have small positions in just to fuck around and hope they blow up. Still looking for something spicy to end this week strong.
Thoughts on IBRX squeeze
IBRX - at least u won’t loose it all … company has a pipeline. If there phase 3 oncology testing is an efficacious as phase 2 (thru the roof with multiple uses now) could bring u way back beyond ur starting point. Same thing with TMC The Metals Company going after $23.6B in minerals at the bottom of the ocean. They have the boat to do it and ALL their test samples returned beyond expectations potential
TMC (the metals company going after deep sea minerals valued at $23.6B) BBAI (mini-palantir) IBRX (oncology w/pipeline, efficacyx100 w/surprising results) MELI (South American oversold “Amazon”)
AAYI 10000% … M&A’d to a new ticker and direction sank 80% from $2.50 to $.20 w/in minutes yesterday and def found its bottom today. I doubled down after climbing back 8% today, BUT long way to go bc so ridiculously undervalued. Also loving IBRX - Phase3 oncology upside with established pipeline limiting downside. Exponential Game Changer!!! G’luk :)
Wanna get onto ppl’s radar: TCM (the metals company) vessel’s completed sampling found $23.6B in minerals deep sea drilling, next stop … drill baby drill!!! IBRX small profitable oncology pipeline entering expedited Phase 3 trials after thru the roof phase 2 efficacy …. Big possibilities with limited downside! YYAI - M&A yesterday and ridiculously 80% oversold shedding new company shares, bottomed today and climbed back 8% by close with way more to make up! I am holding shares in all 3 …. G’luck all :)
Nice job! I wanna share too other ppl’s radars: TCM (the metals company) vessel’s completed sampling found $23.6B in minerals deep sea drilling, next stop … drill baby drill!!! IBRX small profitable oncology pipeline entering expedited Phase 3 trials after thru the roof phase 2 efficacy …. Big possibilities with limited downside! YYAI - M&A yesterday and ridiculously 80% oversold shedding new company shares, bottomed today and climbed back 8% by close with way more to make up! I am holding shares in all 3 …. G’luck all :)
TCM (the metals company) vessel’s completed sampling found $23.6B in minerals deep sea drilling, next stop … drill baby drill!!! IBRX small profitable oncology pipeline entering expedited Phase 3 trials after thru the roof phase 2 efficacy …. Big possibilities with limited downside! YYAI - bought yesterday and ridiculously 80% oversold shedding new company shares, bottomed today and climbed back 8% by close with way more to make up! I am holding shares in all 3 …. G’luck all :)
I’m hoping I scooped up YYAI after hours last night 🤞🏼 love that call and also IBRX (phase 3 oncology trials underway and results from 2 were thru the roof efficacy). Also TMC the metals company as a moonshot - they’re small company with a big boat looking to do deep sea drilling for $23.6B in minerals
Where are my fellow IBRX bag holders at from last year ✋🏻
DISCLOSURE: I currently hold 30k shares of $IBRX I’m not sure we’ll see a squeeze on this one. More like, the shorts will just slowly fade away. The company is already FDA approved with rapidly growing revenue. And a single insider owns almost 700M shares (yes outstanding shares is almost 1B), and he’s stated he doesn’t plan to sell it. He wants to turn it into a self sufficient pharma giant. I think this is a great long term hold, but movement on this stock will be earnings based, not some binary event bio short squeeze. This is not financial advice.
$IBRX is the ticker for anyone wondering
I am all in, love IBRX!
IBRX is beginning. 39% of the float is short. Short availability is down to 200k from being consistently 1+ million. Price has been going up steadily since mid-august, up about 20%. The company plans to release new research next week, likely catalyzing significant price action🚀
A **76.59% short float** makes $IBRX **highly vulnerable to a massive squeeze,** one of the most extreme setups in the market now. If price clears $3 and volume surges, expect **volatile upside**, possibly 100–500% short-term gain potential. This is the next one!
A **76.59% short float** makes $IBRX **highly vulnerable to a massive squeeze,** one of the most extreme setups in the market now. If price clears $3 and volume surges, expect **volatile upside**, possibly 100–500% short-term gain potential. This is the next one!
A **76.59% short float** makes IBRX **highly vulnerable to a massive squeeze,** one of the most extreme setups in the market now. If price clears $3 and volume surges, expect **volatile upside**, possibly 100–500% short-term gain potential. Better than ORCL
That company is IXHL not IBRX, ImmunityBIO
Does anyone have any stocks on their radar for the next month? Let's say someone had $2000 to put somewhere, looking to hold for about a month. Any suggestions of stocks that are on your watchlists? Im in PRPH and IBRX, good luck to all!
IBRX isn't the first bio company that Soon started. There's a reason he's a minority owner of the Lakers. I'm not sure I'd call him useless at business. He knows what he's doing, even if he's not perfect at it. My ex worked for a company like this. Most of them end up bankrupt. IBRX will likely be sold at some point at a number that Soon wants. There are a lot worse companies to be a speculative bag holder, and I saw that as one (though I was lucky and got in at literally their lowest point, so I'm still up close to 100% at the current price.
Keeping an eye on $IBRX. Someone recently bought the equivalent of a day’s worth of volume
Look at IBRX. FDA approval, sky rocket. Now its sitting at around 2.50
I can’t wait for the short squeeze. IBRX on Lung data after close and inevitable FDA label expansion for Anktiva/ Bioshield. https://preview.redd.it/3ufna70swtnf1.jpeg?width=960&format=pjpg&auto=webp&s=11667d419f09e60a5a2ed4b98cfc888ce4e84f3c
I took the Short Float % from FinViz - [https://elite.finviz.com/quote.ashx?t=IBRX&p=d](https://elite.finviz.com/quote.ashx?t=IBRX&p=d) I took the BLA catalyst dates from BioPharma - [https://biopharmawatch.com/company/IBRX](https://biopharmawatch.com/company/IBRX)
Hopefully this means my IBRX postion goes nuts
9/3 watching opening for IBRX, FUBO, HIT, and RMTI. Then will move accordingly.
In on $IBRX and $IFRX. Probably just for next week. At least $IFRX had a good day friday
IBRX, primed for squeeze, shorts about to get rekkt 100%
The device does nothing but slow cell division. So while I agree with the assessment that we need trial outcomes to tell us whether these people really have a complete response, I must point out that these devices do not cause complete responses in glioblastoma patients. And that is the exact claim already put out by IBRX. As a strategy it makes sense: put the tumor development on pause and then hit it with a immunotherapy and bev which slows the growth of veins to the tumor. I can totally see that cleaning up the tumor effectively, but it will be a while before they have really proven this.
IBRX, aftermarket move incoming...
Thought I read earlier IBRX had the fast track there?
IBRX, delayed reaction short squeeze on news! Ton of shorts about to get rekkt
#IBRX Casually curing cancer and no one cares 💀
#IBRX Literally curing cancer and for some reason markets don't care 😭?
IBRX up another percent, so re-commenting this. IBRX short share availability has dropped 90% today. Short interest is at 40%. Already up 6%. Will be next week’s OPEN or TLRY or whatever.
IBRX. Short share availability has dropped 90% today. Short interest is at 40%. Already up 5%. Will be next week’s OPEN or TLRY or whatever.
IBRX Still have high hopes, just bought too much at a high price.
Roll into IBRX. It’s about to pop very soon $50 plus
IBRX will 🌕this week after phase 1 test success. 🚀
IBRX. Up 16% today, 40% of the float is short. Just announced major lymphoma treatment breakthroughs. Perfect for anybody looking for a place to put their BLSH gains.
IBRX quietly having a great day, one of the most shorted stocks.
Looks like $IBRX has finally found the cure for cancer... It's up dolla feety sense.
IBRX looks not to shabby on the long run
IBRX. This is my gambling account essentially so I just full port into positions.
DDD, IBRX, MVIS anyone of these can and will easily has back to $7-$10
MVIS, DDD, IBRX easy hold and load at these prices.
I just decided to go long and bought more. There are few stocks like this that impress me with the product, and most won’t pay off well in the short term. I’m big into COSM, ICU, and IBRX. Was a big fan of KULR until they stopped being focused on their battery tech, though I still have a few shares.
Keep an eye on IBRX. Over 84 percent short. This is a 2B+ company owned by over 90 percent by insiders.
$IBRX has over 84% of its float sold short. 10+ days to cover.
How about IBRX, cancer cure stock, heavily shorted over 80 percent. 😊
Is IBRX the next pump & dump?
Any update on IBRX short shares?
IBRX can be a huge squeeze if we get people on board, over 90% shorted and has insane research
IBRX is the biotech for me.
I bought right before approval. The thought wasn't the rumor just that at some point companies like that will get bought. It was more a buy/hold kind of situation. These types of companies don't typically become the next Regeneron, but they get acquired eventually. I'm kind of in the same boat with IBRX, but I managed to time the market and basically get it at its lowest point, so I'm still up for more than 2x what I put in. The hard part though was it being up considerably at one point, and I didn't sell.
IBRX short interest overall isn’t crazy, but adjusting for float, it’s more like 60%. Hasn’t start to run yet and think it goes next.
IBRX? Publuc Float 120 MIL shares and 80 MIL appx are short...
What is your opinion on IBRX? 80% short float
Can you post on wallstreetbets about IBRX? I tried, didn’t let me, I guess am new. Someone posted OPEN now over 200 percent and still climbing
Plus there is first line trials coming now with IBRX Anktiva with Merck’s Keytruda
Short version is I get a notification my shares are loaned out when they are with the interest rate they're loaned at (the higher that is the more demand - the interest rate on IBRX is actually typically relatively low). Seen the cycle 3x so far where those shares get returned and a spike happens, presumably because shorts had covered.
IBRX, short is higher today 10+ days to cover. This week will pump
$IBRX up 5 cents, looks like they have figured a way to beat cancer.
Are there any good runners this morning? I'm watching IBRX this morning solely on the news last night.
Thoughts on the $IBRX news for PM prices? There seems to be AH news released that looks promising.
Got a large IBRX (ImmunityBio) position, maybe a bit larger than is comfortable exposure wise. They got UK MHRA approval last Friday for anktiva, after getting FDA approval for treatment of NMIBC in May 24. EMA (EU) approval should also come through this year, the Saudis want to roll this out by mid August. Mode of action of the drug works on most solid tumors, especially when paired with their NK cell therapy. That means that the TAM is basically 40% of all people with cancer, which is quite a bit more than the 1 cancer they have approval for right now. Insiders hold >80% of the stock and it’s shorted to a similar percentage at any given time with currently 38 days to cover. There are so many ways this can go right, the assymetrical upside is insane, and so couldn’t be more bullish on this company.
IBRX Ramping up sales of an approved product and multiple in the pipeline with approvals this year
I’m in IBRX, just not sure about the upcoming quarter and potential dilution moving forward to support their expansion. However, upside potential for next 3 years is enormous based on their pipeline and favorable FDA administration
IBRX Immunity Bio already moved beyond maybe.
Yep I invested with them as well. Stay away from IBRX a dilution machine and very shareholder unfriendly.
Looks like IBRX is a winner jumping today and soon to jump above $10
With the upcoming announcements of apple‘s new products using liquid metal. liquid metals stock symbol LQMT should take off sitting right now about $.11 watch this thing jumped to 20 bucks in the next week. Hopefully this makes a lot of people money. Another big gainer for today is IBRX they’re gonna figure out the cure for cancer .
$IBRX $AUTL $BURU $FAAS diamond holders will be rewarded
IBRX up 10% today. FDA approval this week on their Cancer drug. Plus Saudi interest in the company. High short interest. This thing could rocket soon. Not FA. Just my 2cents.
I absolutely love IBRX. It has the ONLY treatment for leukopenia, one of the most common causes of death in cancer patients. Amazing stuff.
Wolf has jumped 40% last 2 days. 20 cents each day. There’s a lot of FTDs out there needing to be filled today and tommorow. They have been on RegSho list for about 20 days straight. Maybe another good day. Just putting that out there. IBRX has been making some moves this week also. Has a large short position. They got FDA approval for a cancer drug this past Monday. It should rocket soon.
IBRX!!! They will cure cancer search them. They already are starting to gain momentum and jumping. Can be well over 10x by the end of the year.
All in on IBRX!! They will be the company to cure cancer!!!!
IBRX ImmunityBio Receives Expanded FDA Authorization to Treat Lymphopenia in Cancer Patients. How high will this stock climb?
IBRX ImmunityBio Receives Expanded FDA Authorization to Treat Lymphopenia in Cancer Patients. How high will this stock climb?
IBRX ImmunityBio Receives Expanded FDA Authorization to Treat Lymphopenia in Cancer Patients. How high will this stock climb?
All in on IBRX!!! Watch it grow from $2.90 to $30.00 a share this year. And then beyond. However you’re always better off putting your first 10k in to a mutual fund or ETF that follows the S&P 500. Learn about their portfolio holdings and how to evaluate stocks. Then start investing in individual stocks and diversify. Maybe even just focusing on dividend paying stocks. It’s a good beginning strategy until you learn more about stocks and how to evaluate and invest. Remember there’s a difference between investing and daytrading. Have your rules in place and stick to them and change as you learn more and tweak your investment strategy.
What is everyone’s thoughts on IBRX? Will they be the ones to cure cancer? I’m all in.